Ototoxicity: AN Argument for Evaluation of the Cochlea in Safety Testing in Animals

Toxicologic Pathology

Volumn 28, Issue 1, 2000, Pages 137-141

  Mattsson, Joel L ^a  

^a DOW AGROSCIENCES LLC   (United States)

Author keywords

Audiometry; brain stem auditory evoked response; cochlear pathology; hearing loss; laboratory animals; ototoxicity; reflex modulation audiometry; safety testing

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; DIURETIC AGENT; STYRENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; COCHLEA INJURY; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DOG; DRUG SAFETY; EVOKED AUDITORY RESPONSE; HISTOPATHOLOGY; MALE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL;

ANIMALS; COCHLEA; COCHLEAR DISEASES; DOGS; HEARING DISORDERS; HUMANS; RATS;

ANIMALIA; CANIS FAMILIARIS; MAMMALIA; RODENTIA;

EID: 0033979675     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262330002800117     Document Type: Article

References (28)

1. Brown RD, Henley CM, Penny JE, Kupetz S. (1985). Link between functional and morphological changes in the inner ear—Functional changes produced by ototoxic agents and their interactions. Arch Toxicol Suppl 8: 240-250.
2. Campbell KC, Durrant J. (1993). Audiologic monitoring for ototoxicity. Otolaryngol Clin North Am 26: 903-914.
3. Cary R., Clarke S., Delic J. (1997). Effects of combined exposure to noise and toxic substances—Critical review. Ann Occup Hyg 41: 455-465.
4. Coupland SG, Ponton CW, Eggermont JJ, Bowen TJ, Grant RM (1991). Assessment of cisplatin-induced ototoxicity using derived-band ABRs. Int J Pediatr Otorhinolaryngol 22: 237-248.
5. Crofton KM, Dean KF, Ménache MG, Janssen R. (1990). Trimethyltin effects on auditory function and cochlear morphology. Toxicol Appl Pharmacol 105: 123-132.
6. Crofton KM, Zhao X. (1993). Mid-frequency hearing loss in rats following inhalation exposure to trichloroethylene: Evidence from reflex modification audiometry. Neurotoxicol Teratol 15: 413-423.
7. Dreschler WA, van der Hulst RJ, Tange RA, Urbanus NA (1985). The role of high-frequency audiometry in early detection of ototoxicity. Audiology 24: 387-395.
8. Dreschler WA, van der Hulst RJ, Tange RA, Urbanus NA (1989). Role of high-frequency audiometry in the early detection of ototoxicity. II. Clinical aspects. Audiology 28: 211-220.
9. Fausti SA, Larson VD, Noffsinger D., Wilson RH, Phillips DS, Fowler CG (1994). High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear 15: 232-239.
10. Goldey ES, Crofton KM (1998). Thyroxine replacement attenuates hypothyroxinemia, hearing loss, and motor deficits following developmental exposure to Aroclor 1254 in rats. Toxicol Sci 45: 94-105.
11. Heffner HE, Heffner RS, Contos C., Ott T. (1994). Audiogram of the hooded Norway rat. Hearing Res 73: 244-247.
12. Henley CM, Rybak LP (1993). Developmental ototoxicity. Otolaryngol Clin North Am 26: 903-914.
13. Hoffman DW, Whitworth CA, Jones-King KL, Rybak LP (1988). Potentiation of ototoxicity by glutathione depletion. Ann Otol Rhinol Laryngol 97: 36-41.
14. Kuzel RA, Smith JM, Trennery PN (1990). Screening procedure for assessment of ototoxicity in the common marmoset. J Pharmacol Methods 24: 9-18.
15. Mason JA, Herrmann KR (1998). Universal infant hearing screening by automated auditory brainstem response measurement. Pediatrics 101: 221-228.
16. Mattsson JL, Boyes WK, Ross JF (1992). Incorporating evoked potentials into neurotoxicity test schemes. In: Neurotoxicology, Tilson H, Mitchell C (eds). Raven Press, New York, pp 125-145.
17. Mehl AL, Thomson V. (1998). Newborn hearing screening: The great omission. Pediatrics 101: e4 (abstract).
18. Meyerhoff WL (1979). Hypothyroidism and the ear: Electrophysiological, morphological, and chemical considerations. Laryngoscope 89(suppl 19): 1-25.
19. Morlet T., Ferber-Viart C., Putet G., Sevin F., Duclaux R. (1998). Auditory screening in high-risk pre-term and full-term neonates using transient evoked otoacoustic emissions and brainstem auditory evoked potentials. Int J Pediatr Otorhinolaryngol 45: 31-40.
20. Peterson EA, Heaton WC, Wruble SD (1969). Levels of auditory response in fissiped carnivores. J Mammal 50: 566-578.
21. Rybak LP (1992). Hearing: The effect of chemicals. Otolaryngol Head Neck Surg 106: 677-686.
22. Seligmann H., Podoshin L., Ben-David J., Fradis M., Goldsher M. (1996). Drug-induced tinnitis and other hearing disorders. Drug Safety 14: 198-212.
23. Sullivan MJ, Rarey KE, Conolly RB (1988). Ototoxicity of toluene in rats. Neurotoxicol Teratol 10: 525-530.
24. Thomas WG (1982). Clinical assessment of auditory dysfunction. Environ Health Perspect. 44: 67-75.
25. Uimonen S., Maki-Torkko E., Sorri M. (1998). Hearing and occupation. Int J Circumpolar Health 57: 156-161.
26. Wessex Universal Neonatal Hearing Screening Trial Group (1998). Controlled trial universal neonatal screening for early identification of permanent childhood hearing impairment. Lancet 352: 1957-1964.
27. Yano BL, Dittenber DA, Albee RR, Mattsson JL (1992). Abnormal auditory brainstem responses and cochlear pathology in rats induced by an exaggerated styrene exposure regimen. Toxicol Pathol 20: 1-6.
28. Young JS, Fechter LD (1986). Trimethyltin exposure produces an unusual form of toxic auditory damage in rats. Toxicol Appl Pharmacol 82: 87-93.